Sep 25, 2019

Sailing Together, in Pursuit of Health and Wellness SIRIO Inscribed in A-share Market

At the sound of the listing bell of the Shenzhen Stock Exchange on September 25, 2019, SIRIO Pharma Co. Ltd(share code: 300791)is officially listed on the A-share Market with an opening price of RMB 54.73 and closing price at RMB 76.60, an immediate increase of 39.96%.

At the sound of the listing bell of the Shenzhen Stock Exchange on September 25, 2019, SIRIO Pharma Co. Ltdshare code: 300791is officially listed on the A-share Market with an opening price of RMB 54.73 and closing price at RMB 76.60, an immediate increase of 39.96%.

 

Founded in 1993, SIRIO has gone through more than 25 years of observation and participation in the Chinese nutrition and wellness industry, with continuous commitment and dedication to plowing the field of R&D and production of health foods. Oriented by the consumers’ needs, it has constantly developed technologies for multiple dosage forms and product applications, providing its customers, both home and abroad, with one-stop product solutions that integrate product R&D, technical design, manufacturing, and technology services, enabling fast transition from health requirements to real products and boosting the overall health industry development.

 

As the Chinese economy is getting more prosperous, people’s aspirations for a better life become an ever-increasing possibility. The issuance of the national strategy Outline of Healthy China 2030 signifies the priority changes from treating diseases to maintaining health, indicating unprecedented opportunities emerging from the health industry. 

 

Patrick Lin, president of the company, said: “Just because SIRIO has conformed to the trend, such steady but fast growth was possible. Over the recent 10 years, SIRIO has accelerated its development. While securing the Chinese market, we have established marketing centers in Americas and Europe, acquired European factories, adding to the stockpile of three major Sino-German R&D centers and four modern production bases. SIRIO today has grown into a comprehensive nutrition and health service provider with certain global influence. With its IPO, I have conviction that SIRIO can allocate more top market resources, propel itself to shoulder more social responsibilities and create a global health and technology brand that comes from China.”

     

This listing will spur SIRIO for another leap-forward. Our company will seize the development opportunity, continue with the strategies for innovating technologies and “going international” and unceasingly improve innovation and operation capabilities, giving back to investors and the community via our outstanding performance. SIRIO will stay true to the initial aspirations of bringing values to health and safeguard the healthy, colorful and happy life for mankind.

 

Company profile

The contract manufacturer in compliance with the worldwide up-to-date GMP standard for all dietary supplements including softgel, capsule, tablet, powder, gummy vitamins and oral liquid